Andrew Gaffney, PhD

STEMCELL Technologies, Inc., USA

Andrew Gaffney completed his PhD in pediatric oncology at the University of Leeds, UK, where he successfully created a disease model of Ewing sarcoma using human embryonic stem cells. Andrew joined STEMCELL Technologies in 2014 and is the Strategic Alliances Manager in the field of pluripotent stem cell biology.

Presentation(s):

• ADVANCING NEUROLOGICAL AND RETINAL RESEARCH WITH GENETICALLY DIVERSE HUMAN IPSC-DERIVED CELLULAR MODELS

  Wednesday, June 11, 2025
  12:30 PM – 1:00 PM HK Time

• METABOLIC UNDERPINNINGS OF STEM CELLS

  Thursday, June 12, 2025
  8:30 AM – 10:00 AM HK Time